Figure 2

Evaluation of the Antihyperglycaemic Activities, Safety and Phytochemical Profile of Celtis zenkeri Engl

Marcus Durojaye Ayoola*, Akintunde Samuel Odediran, Samson Oluwaseyi Famuyiwa, Moyinoluwa Oluwagbemi, Lateefat Idowu Afolabi, Farouk Adedeji Oladoja and Oluwabusayo Emmanuel Kasumu

Published: 14 July, 2023 | Volume 7 - Issue 1 | Pages: 036-044

apps-aid1042-p002

Figure 2:

Plate 2: Photomicrograph of the histology of pancreatic tissue A: Control group, B-D: Treatment groups with 250, 500 and 1000 mg/kg of Celtis zenkeri extract, respectively. (H&E, x400).

Read Full Article HTML DOI: 10.29328/journal.apps.1001042 Cite this Article Read Full Article PDF

More Images

Similar Articles

  • Evaluation of the Antihyperglycaemic Activities, Safety and Phytochemical Profile of Celtis zenkeri Engl
    Marcus Durojaye Ayoola*, Akintunde Samuel Odediran, Samson Oluwaseyi Famuyiwa, Moyinoluwa Oluwagbemi, Lateefat Idowu Afolabi, Farouk Adedeji Oladoja and Oluwabusayo Emmanuel Kasumu Marcus Durojaye Ayoola*, Akintunde Samuel Odediran, Samson Oluwaseyi Famuyiwa, Moyinoluwa Oluwagbemi, Lateefat Idowu Afolabi, Farouk Adedeji Oladoja, Oluwabusayo Emmanuel Kasumu. Evaluation of the Antihyperglycaemic Activities, Safety and Phytochemical Profile of Celtis zenkeri Engl. . 2023 doi: 10.29328/journal.apps.1001042; 7: 036-044
  • Benefits of using SLGT2 Inhibitors for Patients with CDK and DM2 to Reduce Mortality Risks
    Pandora Eloa Oliveira Fonseca, Jeremias Aguiar Azevedo, Sara Maria Gomes Bié and Sávio Benvindo Ferreira* Pandora Eloa Oliveira Fonseca, Jeremias Aguiar Azevedo, Sara Maria Gomes Bié, Sávio Benvindo Ferreira*. Benefits of using SLGT2 Inhibitors for Patients with CDK and DM2 to Reduce Mortality Risks. . 2024 doi: 10.29328/journal.apps.1001055; 8: 041-046

Recently Viewed

Read More

Most Viewed

Read More

Help ?